Clinical Trial Update: The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q). [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the efficacy of azacitidine with or without lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with del…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Revlimid (lenalidomide)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Nordic MDS Group | Conditions: Myelodysplastic Syndrome, Acute Myelogenous Leukemia | Phase 2 | Status: UNKNOWN